Reactive aldehydes – second messengers of free radicals in diabetes mellitus

References

• Maechler P. Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic beta-cells. Cell Mol Life Sci 2002;59:1803–1818.
   PubMed Web of Science ®Google Scholar
• Tarasov A, Dusonchet J, Ashcroft F. Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux. Diabetes 2004;53:S113–S122.
   PubMed Web of Science ®Google Scholar
• Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB, Rorsman P. Novel aspects of the molecular mechanisms controlling insulin secretion. J Physiol 2008;586: 3313–3324.
   Google Scholar
• Li N, Stojanovski S, Maechler P. Mitochondrial hormesis in pancreatic β cells: does uncoupling protein 2 play a role?. Oxid Med Cell Longev 2012;2012:740849.
   PubMed Web of Science ®Google Scholar
• Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004;53:S119–S124.
   PubMed Web of Science ®Google Scholar
• Köhnke R, Mei J, Park M, York DA, Erlanson-Albertsson C. Fatty acids and glucose in high concentration down-regulates ATP synthase beta-subunit protein expression in INS-1 cells. Nutr Neurosci 2007;10:273–278.
   PubMed Web of Science ®Google Scholar
• Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 2008;36:343–347.
   PubMed Web of Science ®Google Scholar
• Rhodes C. Type 2 diabetes-a matter of beta -cell life and death?. Science 2005;307:380–384.
   PubMed Web of Science ®Google Scholar
• Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 2004;53:2271–2280.
   PubMed Web of Science ®Google Scholar
• Tiedge M, Lortz S, Munday R, Lenzen S. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 1998;47:1578–1585.
   PubMed Web of Science ®Google Scholar
• Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 2007;56:1783–1791.
   PubMed Web of Science ®Google Scholar
• Zivkovic M, Poljak-Blazi M, Zarkovic K, Mihaljevic D, Schaur RJ, Zarkovic N. Oxidative burst of neutrophils against melanoma B16-F10. Cancer Lett 2007;246:100–108.
   PubMed Web of Science ®Google Scholar
• Jaganjac M, Cacev T, Cipak A, Kapitanović S, Gall Troselj K, Zarković N. Even stressed cells are individuals: second messengers of free radicals in pathophysiology of cancer. Croat Med J 2012;53:304–309.
   PubMed Web of Science ®Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stressactivated signaling pathways mediators of insulin resistance and β-cell dysfunction?. Diabetes 2003;52:1–8.
   PubMed Web of Science ®Google Scholar
• Maechler P, Jornot L, Wollheim CB. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 1999;274:27905–27913.
   PubMed Web of Science ®Google Scholar
• Li N, Brun T, Cnop M, Cunha DA, Eizirik DL, Maechler P. Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction. J Biol Chem 2009; 284:23602–23612.
   PubMedGoogle Scholar
• Jaganjac M. Possible involvement of granulocyte oxidative burst in Nrf2 signaling in cancer. Indian J Med Res 2010;131:609–616.
   PubMed Web of Science ®Google Scholar
• Lei XG, Vatamaniuk MZ. Two tales of antioxidant enzymes on β cells and diabetes. Antioxid Redox Signal 2011;14: 489–503.
   PubMed Web of Science ®Google Scholar
• Boucher M-J, Selander L, Carlsson L, Edlund H. Phosphorylation marks IPF1 = PDX1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms. J Biol Chem 2006; 281:6395–6403.
   PubMed Web of Science ®Google Scholar
• Ponugoti B, Dong G, Graves DT. Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp Diabetes Res 2012;2012:939751.
   PubMedGoogle Scholar
• Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal 2011;14:593–605.
   PubMed Web of Science ®Google Scholar
• Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001;105:745–755.
   PubMed Web of Science ®Google Scholar
• Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, Grey ST, Lowell BB. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003;112:1831–1842.
   PubMed Web of Science ®Google Scholar
• Matsuoka TA, Kaneto H, Miyatsuka T, Yamamoto T, Yamamoto K, Kato K, et al. Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes 2010;59:1709–1720.
   PubMed Web of Science ®Google Scholar
• Harmon JS, Bogdani M, Parazzoli SD, Mak SS, Oseid EA, Berghmans M, et al. beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology 2009;150:4855–4862.
   PubMed Web of Science ®Google Scholar
• Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 2006;41:177–184.
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058–1070.
   PubMed Web of Science ®Google Scholar
• Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009;58:1229–1236.
   PubMed Web of Science ®Google Scholar
• Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006;212:167–178.
   PubMed Web of Science ®Google Scholar
• Pamplona R. Advanced lipoxidation end-products. Chem Biol Interact 2011;192:14–20.
   PubMed Web of Science ®Google Scholar
• Suzuki D, Miyata T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern Med 1999;38:309–314.
   PubMed Web of Science ®Google Scholar
• Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001;280:E685–E694.
   PubMed Web of Science ®Google Scholar
• Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, et al. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha- dependent pathway. Diabetes 2008;57:460–469.
   PubMed Web of Science ®Google Scholar
• Schramm A, Matusik P, Osmenda G, Guzik TJ. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 2012;56:216–231.
   PubMed Web of Science ®Google Scholar
• Clynes R, Moser B, Yan SF, Ramasamy R, Herold K, Schmidt AM. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med 2007; 7:743–751.
   PubMed Web of Science ®Google Scholar
• Lim M, Park L, Shin G, Hong H, Kang I, Park Y. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Ann N Y Acad Sci 2008;1150:311–315.
   PubMed Web of Science ®Google Scholar
• Sangle GV, Zhao R, Mizuno TM, Shen GX. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 2010;151:4455–4466.
   PubMed Web of Science ®Google Scholar
• Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, et al. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 2008;105:1739–1744.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Vazdar M, Jurkiewicz P, Hof M, Jungwirth P, Cwiklik L. Behavior of 4-hydroxynonenal in phospholipid membranes. J Phys Chem B 2012;116:6411–6415.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 2009; 44:625–633.
   PubMed Web of Science ®Google Scholar
• Jaganjac M, Matijevic T, Cindric M, Cipak A, Mrakovcic L, Gubisch W, Zarkovic N. Induction of CMV-1 promoter by 4-hydroxy-2-nonenal in human embryonic kidney cells. Acta Biochim Pol 2010;57:179–183.
   PubMed Web of Science ®Google Scholar
• Jaganjac M, Poljak-Blazi M, Schaur RJ, Zarkovic K, Borovic S, Cipak A, et al. Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression. Clin Exp Immunol 2012;170:178–185.
   PubMed Web of Science ®Google Scholar
• Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 2003;24: 281–291.
   PubMedGoogle Scholar
• Go YM, Halvey PJ, Hansen JM, Reed M, Pohl J, Jones DP. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol 2007;171:1670–1681.
   PubMed Web of Science ®Google Scholar
• Page S, Fischer C, Baumgartner B, Haas M, Kreusel U, Loidl G, et al. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem 1999;274:11611–11618.
   PubMed Web of Science ®Google Scholar
• Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol 2002;64:1019–1026.
   PubMed Web of Science ®Google Scholar
• Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008;283:21837–21841.
   PubMed Web of Science ®Google Scholar
• Demozay D, Mas JC, Rocchi S, Van Obberghen E. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes 2008;57:1216–1226.
   PubMed Web of Science ®Google Scholar
• Ingram KH, Hill H, Moellering DR, Hill BG, Lara-Castro C, Newcomer B, et al. Skeletal muscle lipid peroxidation and insulin resistance in humans. J Clin Endocrinol Metab 2012; 97:1182–1186.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, et al. Pathological aspects of lipid peroxidation. Free Radic Res 2010;44:1125–1171.
   PubMed Web of Science ®Google Scholar
• Shen XP, Li J, Zou S, Wu HJ, Zhang Y. The relationship between oxidative stress and the levels of serum circulating adhesion molecules in patients with hyperglycemia crises. J Diabetes Complications 2012;26:291–295.
   PubMed Web of Science ®Google Scholar
• Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res 2011;1369: 194–202.
   PubMed Web of Science ®Google Scholar
• Lupachyk S, Shevalye H, Maksimchyk Y, Drel VR, Obrosova IG. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function. Free Radic Biol Med 2011;50:1400–1409.
   PubMed Web of Science ®Google Scholar
• Gleissner CA, Sanders JM, Nadler J, Ley K. Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:1137–1143.
   PubMed Web of Science ®Google Scholar
• Pennathur S, Ido Y, Heller JI, Byun J, Danda R, et al. Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes. J Biol Chem 2005;280:22706–22714.
   PubMed Web of Science ®Google Scholar
• Singh SP, Niemczyk M, Saini D, Awasthi YC, Zimniak L, Zimniak P. Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 2008;47:3900–3911.
   PubMed Web of Science ®Google Scholar
• Sohet FM, Neyrinck AM, Dewulf EM, Bindels LB, Portois L, Malaisse WJ, et al. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice. Br J Nutr 2009;102:462–469.
   PubMed Web of Science ®Google Scholar
• Dasuri K, Ebenezer P, Fernandez-Kim SO, Zhang L, Gao Z, Bruce-Keller AJ, et al. Role of physiological levels of 4-hydroxynonenal on adipocyte biology: implications for obesity and metabolic syndrome. Free Radic Res 2013; 47:8–19.
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Ilic Z, Jurin M, Scahur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 1993;11: 279–286.
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Schaur RJ, Puhl H, Jurin M, Esterbauer H. Mutual dependence of growth modifying effects of 4-hydroxy-nonenal and fetal calf serum in vitro. Free Radic Biol Med 1994;16: 877–884.
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Cipak A, Jaganjac M, Borovic S, Zarkovic K. Pathophysiological relevance of aldehydic protein modifications. J Proteomics 2013, in press doi:pii:S1874-3919(13)00066-3.10.1016/j.prot.2013.02.004
   PubMed Web of Science ®Google Scholar
• Zivkovic M, Zarkovic K, Skrinjar LJ, Waeg G, Poljak-Blazi M, Borovic S, et al. A new method for detection of HNE-histidine conjugates in rat inflammatory cells. Croat Chem Acta 2005;78:91–98.
   Web of Science ®Google Scholar
• Srividhya R, Zarkovic K, Stroser M, Waeg G, Zarkovic N, Kalaiselvi P. Mitochondrial alterations in aging rat brain: effective role of (2)- epigallo catechin gallate. Int J Develop Neurosci 2009;27:223–231.
   PubMed Web of Science ®Google Scholar
• Casos K, Zaragoza MC, Zarkovic N, Zarkovic K, Andrisic L, Portero-Otín M, et al. A fish oil-rich diet reduces vascular oxidative stress in apoE-/- mice. Free Radic Res 2010;44:821–829.
   PubMed Web of Science ®Google Scholar
• Augustyniak A, Bartosz G, Cipak A, Duburs G, Horakova L, Luczaj W, et al. Natural and synthetic antioxidants – an updated overview. Free Radic Res 2010;44:1216–1262.
   PubMed Web of Science ®Google Scholar
• Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007;9:813–839.
   PubMed Web of Science ®Google Scholar
• Shevalye H, Lupachyk S, Watcho P, Stavniichuk R, Khazim K, Abboud HE, Obrosova IG. Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress. Endocrinology 2012;153:1152–1161.
   PubMed Web of Science ®Google Scholar
• Torloni MR, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10:194–203.
   PubMed Web of Science ®Google Scholar
• Weng H, Li X, Reece EA, Yang P. SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy. Am J Obstet Gynecol 2012;206:448.e1–7.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Wagner N. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther 2010;125:423–435.
   PubMed Web of Science ®Google Scholar
• Kocalis HE, Turney MK, Printz RL, Laryea GN, Muglia LJ, Davies SS, et al. Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARdelta) in mice leads to increased susceptibility to diet-induced obesity. PLoS One 2012;7:e42981.
   Web of Science ®Google Scholar
• Salvado L, Serrano-Marco L, Barroso E, Palomer X, Vazquez-Carrera M. Targeting PPARbeta/delta for the treatment of type 2 diabetes mellitus. Expert Opin Ther Targets 2012;16:209–223.
   PubMed Web of Science ®Google Scholar
• Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 2006;103:3444–3449.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 2003;100:15924–15929.
   PubMed Web of Science ®Google Scholar
• Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003;113: 159–170.
   PubMed Web of Science ®Google Scholar
• Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, et al. A selective peroxisome proliferator- activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 2001;98:5306–5311.
   PubMed Web of Science ®Google Scholar
• Mottillo EP, Bloch AE, Leff T, Granneman JG. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) alpha and delta in brown adipocytes to match fatty acid oxidation with supply. J Biol Chem 2012;287: 25038–25048.
   PubMed Web of Science ®Google Scholar
• Naruhn S, Meissner W, Adhikary T, Kaddatz K, Klein T, Watzer B, et al. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist. Mol Pharmacol 2010;77:171–184.
   PubMed Web of Science ®Google Scholar
• Yu Z, Schneider C, Boeglin WE, Brash AR. Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha. Lipids 2007;42:491–497.
   PubMed Web of Science ®Google Scholar
• Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999;3: 397–403.
   PubMed Web of Science ®Google Scholar
• Lamers C, Schubert-Zsilavecz M, Merk D. Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present). Expert Opin Ther Pat 2012;22:803–841.
   PubMed Web of Science ®Google Scholar
• Maltarollo VG, Honorio KM. Ligand- and structure-based drug design strategies and PPARdelta/alpha selectivity. Chem Biol Drug Des 2012;80:533–544.
   PubMed Web of Science ®Google Scholar
• Batista FA, Trivella DB, Bernardes A, Gratieri J, Oliveira PS, Figueira AC, et al. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding. PLoS One 2012;7:e33643.
   PubMed Web of Science ®Google Scholar
• Shearer BG, Steger DJ, Way JM, Stanley TB, Lobe DC, Grillot DA, et al. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol 2008;22:523–529.
   PubMedGoogle Scholar
• Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, Goreham D, et al. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta) – synthesis and biological activity. Bioorg Med Chem Lett 2003;13:1517–1521.
   PubMed Web of Science ®Google Scholar
• Ravnskjaer K, Frigerio F, Boergesen M, Nielsen T, Maechler P, Mandrup S. PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction. J Lipid Res 2010;51:1370–1379.
   PubMed Web of Science ®Google Scholar
• Riahi Y, Sin-Malia Y, Cohen G, Alpert E, Gruzman A, Eckel J, et al. The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator- activated receptor delta. Diabetes 2010;59:808–818.
   PubMed Web of Science ®Google Scholar
• Cohen G, Riahi Y, Shamni O, Guichardant M, Chatgilialoglu C, Ferreri C, Kaiser N, Sasson S. Role of lipid peroxidation and PPAR-delta in amplifying glucose-stimulated insulin secretion. Diabetes 2011;60:2830–2842.
   PubMed Web of Science ®Google Scholar
• Cohen G, Riahi Y, Sasson S. Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues. Arch Physiol Biochem 2011;117:131–139.
   PubMedGoogle Scholar
• Riahi Y, Cohen G, Shamni O, Sasson S. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am J Physiol Endocrinol Metab 2010;299:E879–E886.
   PubMed Web of Science ®Google Scholar
• Aldini G, Orioli M, Rossoni G, Savi F, Braidotti P, Vistoli G, et al. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med 2011;15:1339–1354.
   PubMed Web of Science ®Google Scholar
• Sauerhöfer S, Yuan G, Braun GS, Deinzer M, Neumaier M, Gretz N, et al. L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes 2007;56:2425–32.
   PubMed Web of Science ®Google Scholar
• Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 2008;28:569–631.
   PubMed Web of Science ®Google Scholar
• Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal 1999; 1:255–284.
   PubMed Web of Science ®Google Scholar
• Usatyuk PV, Natarajan V. Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvasc Res 2012;83: 45–55.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 2005;49:1044–1049.
   PubMed Web of Science ®Google Scholar